<?xml version="1.0" encoding="UTF-8"?>
<p>Daily rates of patients with CINV events (experiencing emesis and/or use of rescue medication) remained between 13% and 15% for APR/GRAN and declined from 16% to 8% over the 5â€‰days for NEPA. The difference between treatment groups (8.0% NEPA and 13.9% APR/GRAN, 95% CI: 1.7%, 10.2%) reached statistical significance on day 5 (Figure 
 <xref ref-type="fig" rid="mdx698-F2">2</xref>
 <bold>)</bold>. 
</p>
